Metraipolis › archive › dc_7137d97ba237
Targeted Biocatalyst Design for Asymmetric Citalopram Conversion in a Membrane Reactor — Europe PMC PMID:41304833
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41304833
- DOI
- 10.3390/pharmaceutics17111497
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T10:50:41.484Z
- SHA-256 of the archived text
4d219aca5d7079191e1fb65440ea2354ed5289f1e4ec624571c979d4c1126126- Stable URL of this page
https://metraipolis.com/documento/dc_7137d97ba237
How to cite
Targeted Biocatalyst Design for Asymmetric Citalopram Conversion in a Membrane Reactor — Europe PMC PMID:41304833 — Europe PMC (en), https://europepmc.org/article/MED/41304833 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7137d97ba237 (Metraipolis archive dc_7137d97ba237, sha256 4d219aca5d7079191e1fb65440ea2354ed5289f1e4ec624571c979d4c1126126)
BibTeX
@misc{dc7137d97ba237,
title = {Targeted Biocatalyst Design for Asymmetric Citalopram Conversion in a Membrane Reactor — Europe PMC PMID:41304833},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41304833},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7137d97ba237; sha256 4d219aca5d7079191e1fb65440ea2354ed5289f1e4ec624571c979d4c1126126},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304833. Agents can read the archived copy with the MCP tool read_document.